Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
3.870
+0.010 (0.26%)
At close: Aug 13, 2025, 4:00 PM
3.990
+0.120 (3.10%)
After-hours: Aug 13, 2025, 6:07 PM EDT
Neuronetics Revenue
Neuronetics had revenue of $38.11M in the quarter ending June 30, 2025, with 131.66% growth. This brings the company's revenue in the last twelve months to $111.11M, up 54.17% year-over-year. In the year 2024, Neuronetics had annual revenue of $74.89M with 4.96% growth.
Revenue (ttm)
$111.11M
Revenue Growth
+54.17%
P/S Ratio
1.70
Revenue / Employee
$155,176
Employees
716
Market Cap
256.89M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
STIM News
- 7 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 14 days ago - NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents - GlobeNewsWire
- 4 weeks ago - Neuronetics Appoints New Chief Financial Officer - GlobeNewsWire
- 2 months ago - Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - GlobeNewsWire
- 2 months ago - Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 3 months ago - Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript - Seeking Alpha